Open-label Study of ASP2151 in Herpes Simplex Patients

Study Comparing the Safety of ASP2151 to Valacyclovir and Placebo in Healthy Volunteers

NCT00870441 ·Status: TERMINATED ·Phase: PHASE1

Evaluating New Formulation of Therapeutic HSV-2 Vaccine

NCT02515175 ·Status: COMPLETED ·Phase: PHASE2

Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine

NCT02114060 ·Status: COMPLETED ·Phase: PHASE2

A Randomized Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 Reactivation

NCT00723229 ·Status: COMPLETED ·Phase: PHASE4

An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.

NCT04950712 ·Status: COMPLETED

Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis

NCT02265913 ·Status: COMPLETED ·Phase: PHASE3

A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3

NCT00000712 ·Status: COMPLETED ·Phase: PHASE2

A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster

NCT05492591 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine

NCT01667341 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study on the Reactogenicity, Safety and Immune Response of a Targeted Immunotherapy Against HSV in Healthy Japanese Participants Aged 18-40 Years

NCT05989672 ·Status: COMPLETED ·Phase: PHASE1

Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection

NCT01915212 ·Status: COMPLETED ·Phase: PHASE1

Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212)

NCT00158483 ·Status: COMPLETED ·Phase: PHASE2

Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon

NCT00209313 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons

NCT00079911 ·Status: TERMINATED ·Phase: PHASE4

Evaluating Safety and Efficacy of Repeat Doses of UB-621in Adult Patients With Recurrent Genital Herpes

NCT04979975 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity

NCT02910284 ·Status: COMPLETED

Drug-Drug Interaction Study: ASP2151 and Ciclosporin

NCT02280421 ·Status: COMPLETED ·Phase: PHASE1

Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

NCT00362297 ·Status: COMPLETED ·Phase: PHASE4

Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)

NCT00371592 ·Status: COMPLETED ·Phase: PHASE2

Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission

NCT00194519 ·Status: COMPLETED ·Phase: PHASE3

A 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected Subjects

NCT05823779 ·Status: UNKNOWN

A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes

NCT06385327 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of UB-621 in Healthy Volunteers

NCT02346760 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes

NCT06698575 ·Status: COMPLETED ·Phase: PHASE1

Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects

NCT00698568 ·Status: COMPLETED ·Phase: PHASE3